Concepedia

The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study

Daniela Kandioler, Sebastian F. Schoppmann, Ronald Zwrtek, Sonja Kappel, Brigitte Wolf, Martina Mittlböck, I. Kührer, Michael Hejna, Ursula Pluschnig, Ahmed Ba‐Ssalamah,

Journal of Thoracic and Cardiovascular Surgery · 2014 · 51 citations · 21 references

DOIFull text

Open access

Concepts

References

21

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot et al. · New England Journal of Medicine · 2012 · 5.5K citations · Full text

, , +14

Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion

Johan T. den Dunnen, Stylianos E. Antonarakis · Human Mutation · 2000 · 1.8K citations · Full text

, , +11

Impact of mutant p53 functional properties on<i>TP53</i>mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

Audrey Petitjean, Ewy A. Mathé, Shunsuke Kato et al. · Human Mutation · 2007 · 1.6K citations · Full text

, , +16

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

The Lancet · 2002 · 1.5K citations

, , +12